You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同佳健康(00286.HK):爱帝宫创始人朱昱霏入主集团董事局
格隆汇 09-20 19:00

格隆汇9月20日丨同佳健康(00286.HK)公布,公司董事会建议将公司现有名称从"Common Splendor International Health Industry GroupLimited"修改为"Aidigong Maternal&Child Health Limited",并将其中文第二名称从"同佳国际健康产业集团有限公司"修改为"爱帝宫母婴健康股份有限公司"。公司会于将召开之股东特别大会上提呈一项特别决议案以考虑及酌情批准建议更改公司名称。

此外,公司建议提名朱昱霏为执行董事、董事会联席主席及行政总裁的候选人,惟须待建议修订细则生效后方可作实。委任朱昱霏亦须待股东于即将召开之股东特别大会上批准后方可作实。于获委任后,朱昱霏将与公司现任董事会主席张伟权共同担任公司董事会联席主席。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account